PG13 Challenges in the treatment of tuberculosis

Postgraduate Course
Chairs: J. Heyckendorf (Hamburg, Germany), R. Duarte (Porto, Portugal)
Aims: Access educational materials here
To help clinicians to confidently manage all tuberculosis patients with the aim of achieving tuberculosis elimination in Europe and elsewhere; to help clinicians treat tuberculosis in patients with whom failure of treatment or adherence could result in drug resistance; and to address concerns regarding heart rate-corrected QT interval (QTc) prolongation with current second-line drugs.
Diagnosing and treating paediatric tuberculosis infections
F. Brinkmann (Bochum, Germany)
WebcastSlide presentation
WebcastSlide presentation
Treating multiple-drug resistant tuberculosis
L. Guglielmetti (Paris, France)
WebcastSlide presentation
WebcastSlide presentation
Treating tuberculosis in patients with comorbidities
R. van Hest (Groningen, Netherlands)
WebcastSlide presentation
WebcastSlide presentation
Treating acute complications and the severely ill patient with tuberculosis
G. Hagan (Solihull (West Midlands), United Kingdom)
WebcastSlide presentation
WebcastSlide presentation
Group assignment
F. Brinkmann (Bochum, Germany), L. Guglielmetti (Paris, France), R. van Hest (Groningen, Netherlands), G. Hagan (Solihull (West Midlands), United Kingdom)
WebcastWebcastSlide presentationSlide presentation
WebcastWebcastSlide presentationSlide presentation
Patient testimonial
L. Vinogradof (Moreni, Romania)
No content made available
No content made available
Patient testimonial
L. Vinogradof (Moreni, Romania)
No content made available
No content made available